Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05691023 · ClinicalTrials.gov registry record
VNS-REHAB At-Home - Post-Market Study for Using the Vivistim System® at Home
A clinical trial of Ischemic Stroke and Upper Extremity Problem, sponsored by MicroTransponder.
- Active
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05691023 is a study of Ischemic Stroke and Upper Extremity Problem that is active but no longer recruiting, run by MicroTransponder. The registered enrollment target is 50 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05691023, a study of Ischemic Stroke and Upper Extremity Problem, is active but no longer recruiting, sponsored by MicroTransponder.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-arm post-market study of up to 150 participants, using up to 50 mobile therapists to conduct up to 36-hours at-home therapy. The study will assess at-home therapy implementation instead of an in-clinic therapy implementation for patients who are commercially implanted with the Vivistim System. Patients will be consented for eligibility if appropriate to be implanted with the Vivistim System per the indications for use (The MicroTransponder® Vivistim® Paired VNS™ System is intended to be used to stimulate the vagus nerve during rehabilitation therapy in order to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with moderate to severe arm impairment.). Study participation includes receiving rehabilitation therapy paired with VNS, provided at the patient's home by a therapist, along with self-activated VNS. All subjects will be commercially implanted with the Vivistim System® after an ischemic stroke prior to Study treatment, although they may be consented prior to implant. It should be noted that the implant surgery is not part of the study.
Conditions Studied
Interventions
- DEVICE Vivistim System
Study Locations (1)
Illinois
- Moxie OT - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05691023
The ClinicalTrials.gov registry entry for NCT05691023 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (97% lower). The listed sponsor is MicroTransponder, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Vivistim System is the first listed.
NCT05691023 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05691023 about?
NCT05691023 is a clinical study titled "VNS-REHAB At-Home - Post-Market Study for Using the Vivistim System® at Home". This is a single-arm post-market study of up to 150 participants, using up to 50 mobile therapists to conduct up to 36-hours at-home therapy. The study will assess at-home therapy implementation instead of an in-clinic therapy implementation for patients who are commercially implanted with the Vivis...
What is the current status of trial NCT05691023?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2023-06-01. Estimated completion is 2028-12-31.
What conditions does trial NCT05691023 study?
This clinical trial studies the following conditions: Ischemic Stroke, Upper Extremity Problem.
What interventions are being tested in trial NCT05691023?
The interventions under investigation include: Vivistim System (DEVICE).
Who is sponsoring clinical trial NCT05691023?
This trial is sponsored by MicroTransponder, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05691023 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Transitions of Care for Stroke Patients
RECRUITING
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.